Travel advisory vs. Manila, Philippines

International advisory vs. Intercontinental Manila
which was a hotel and was located in Makati. For the benefit of customers, I sent a letter by registered mail to said hotel and I requested some
information about said hotel. I have evidence that said letter was received by said hotel, but said hotel did not provide me with any reply until after
I complained to the DTI BTRCP. Even after said Department of Trade and Industry Bureau of Trade Regulation and Consumer Protection endorsed my said letter
to said hotel, said hotel, in a letter dated July 2, 2009, did not provide me with the proofs I requested. For example, my registered letter received by
said hotel contained the following request: "If said hotel has a swimming pool, provide soonest to me, proofs, if any, that said pool is safe for swimming."
Said hotel did not provide me with any proofs that said swimming pool is safe for swimming by humans. The signature which appeared on said letter was
identified was being that of Charles Marshall General Manager.

Travel advisory vs. Manila, Philippines
I have evidence vs. the present Manila Mayor identified as Lim and the present Manila Vice-Mayor identified as Moreno. I believe they violated R.A. 6713. I
have seen security lapses in Manila City Hall, private entities in Manila, including shopping malls, etc.
if any people are injured or killed in Manila due to security lapses in restaurants, shopping malls, hotels, etc., it will not be the concern of the city
government of Manila since the above are private entities. The above statement is based on a statement from a source identified as Ricardo E. De Guzman Chief of Staff Office of the Mayor City of Manila in a letter dated June 19, 2009 and addressed to me. Said letter contained the following statement from said De Guzman:
"Security lapses in shopping malls are not the concern of the city government, being private entites."

Cold and Cough Medicines: Information for Parents
http://www.cdc.gov/features/pediatricColdMeds/

Recent safety concerns have prompted drug manufacturers to change their labels stating that cough and cold medicines should NOT be given to
children younger than age 4. Parents can take some steps now to help keep their children safe.

Each year, thousands of children under age 12 go to emergency rooms after taking over-the-counter cough and cold medicines. Most of these children were unsupervised when they took the medicine.

In response to safety concerns, the leading manufacturers of children's cough and cold medicines are voluntarily changing the labels on these products to state that they should not be used in children younger than 4 years of age.

Previously, the labels stated that these medicines should not be given to children under age 2. Products with the old labels will not be removed immediately from store shelves but are expected to gradually be replaced with products bearing the new labels. Doctors and nurses should be aware of the new labels and alert parents and caregivers about this important change.

Parents can help protect their children by doing the following:
Do

* Throw away old cold and cough medicines labeled for children less than age 4.
* Read the label carefully to see what ingredients are in any medicine you give your child.

Don't

* Don't leave any medicines where your child might be able to reach them.
* Don't tell children that medicine is candy.
* Don't take adult medicines in front of your child.
* Don't give children younger than age 4 any medicines intended for older children.
* Don't give your child two medicines that contain the same ingredients.

For tips on safely managing coughs and colds, talk to your child's doctor or your pharmacist.
More Information

* Revised Product Labels for Pediatric Over-the-Counter Cough and Cold Medicines. Centers for Disease Control and Prevention. MMWR 2008;57:1180.
* FDA Statement Following CHPA's Announcement on Nonprescription Over-the-Counter Cough and Cold Medicines in Children
* Statement from Consumer Healthcare Products Association on the Voluntary Label Updates to Oral OTC Children's Cough and Cold: Medicines
* Tips to Prevent Poisonings, National Center for Injury Prevention and Control
* Schaefer MK, Shehab N, Cohen AL, Budnitz DS. Adverse Events Attributable to Cough and Cold Medications in Children.* Pediatrics. Epub 28 Jan 2008. DOI: 10.1542/peds.2007-3638.

# Page last reviewed: January 14, 2009
# Page last updated: January 14, 2009
# Content source: National Center for Preparedness, Detection, and Control of Infectious Diseases, Division of Healthcare Quality Promotion (DHQP)
# Page maintained by: National Center for Health Marketing, Division of eHealth Marketing
# URL for this page: http://www.cdc.gov/Features/PediatricColdMeds/

FDA: New Public Health Regulation to Improve Egg Safety and Reduce Salmonella Illnesses
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm170788.htm

FDA NEWS RELEASE

For Immediate Release: July 7, 2009


FDA: New Public Health Regulation to Improve Egg Safety and Reduce Salmonella Illnesses

The U.S. Food and Drug Administration today announced a regulation expected to prevent each year 79,000 cases of foodborne illness and 30 deaths caused by consumption of eggs contaminated with the bacterium Salmonella Enteritidis.

The final rule requires preventive measures during the production of shell eggs in poultry houses and requires subsequent refrigeration during storage and transportation.

Egg-associated illness caused by Salmonella is a serious public health problem. Infected individuals may suffer mild to severe gastrointestinal illness, short term or chronic arthritis, or even death. Implementing the preventive measures would reduce the number of Salmonella Enteritidis infections from eggs by nearly 60 percent.

“Preventing harm to consumers is our first priority,” said Margaret A. Hamburg, M.D., Commissioner of Food and Drugs. “Today's action will prevent thousands of serious illnesses from Salmonella in eggs.”

Salmonella Enteritidis can be found inside eggs that appear perfectly normal. If the eggs are eaten raw or undercooked, the bacterium can cause illness. Eggs in the shell become contaminated on the farm, primarily because of infection in the laying hens.

The rule requires that measures designed to prevent Salmonella Enteritidis be adopted by virtually all egg producers with 3,000 or more laying hens whose shell eggs are not processed with a treatment, such as pasteurization, to ensure their safety.

Producers with at least 3,000 but fewer than 50,000 laying hens must comply within 36 months after the rule’s publication. Producers with 50,000 or more laying hens must be in compliance with the rule within 12 months after its publication in the Federal Register.

Under the rule, egg producers must:

* Buy chicks and young hens only from suppliers who monitor for Salmonella bacteria
* Establish rodent, pest control, and biosecurity measures to prevent spread of bacteria throughout the farm by people and equipment
* Conduct testing in the poultry house for Salmonella Enteritidis. If the tests find the bacterium, a representative sample of the eggs must be tested over an 8 week time period (4 tests at 2 week intervals); If any of the four egg tests is positive, the producer must further process the eggs to destroy the bacteria, or divert the eggs to a non-food use
* Clean and disinfect poultry houses that have tested positive for Salmonella Enteritidis
* Refrigerate eggs at 45 degrees Fahrenheit temperature during storage and transportation no later than 36 hours after the eggs are laid.

Egg producers whose eggs receive treatments such as pasteurization still must comply with the refrigeration requirements. Similarly, certain persons such as distributors, packers, or truckers holding or transporting shell eggs also must comply with the refrigeration requirements.

To ensure compliance, egg producers must maintain a written Salmonella Enteritidis prevention plan and records documenting their compliance. Producers (except those who have less than 3000 hens or who sell all their eggs directly to consumers) also must register with the FDA. The FDA will develop guidance and enforcement plans to help egg producers comply with the rule.

The FDA estimated that the rule would provide $1.4 billion in annual public health benefits, at an annual cost of $81 million to the regulated industry, or less than 1 cent per dozen eggs produced in the United States.

During the 1990s, the FDA and the U.S. Department of Agriculture implemented a series of post-egg production safety efforts such as refrigeration requirements designed to inhibit the growth of bacteria that may be in an egg. While these steps limited the growth of bacteria, they did not prevent the initial contamination from occurring.

The new rule is part of a coordinated strategy between the FDA and the USDA’s Food Safety and Inspection Service (FSIS). The FDA and the FSIS will continue to work closely together to ensure that egg safety measures are consistent, coordinated, and complementary.

In addition to the new safety measures being taken by industry, consumers can reduce their risk of foodborne illness by following safe egg handling practices. The FDA reminds consumers to buy eggs that have been refrigerated, make sure eggs in the carton are clean and not cracked, and cook eggs and foods containing eggs thoroughly.

For more information:
http://www.fda.gov/Food/FoodSafety/Product-SpecificInformation/EggSafety/EggSafetyActionPlan/ucm170615.htm

#

RSS Feed for FDA News Releases [what is RSS?]

-
-

Page Last Updated: 07/08/2009
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.